Our Team


Executive Team


Board


Scientific & Medical Adviser



Executive Team

 

Dr Alan Walker : Chief Executive Officer

Alan is an experienced CEO with 51 years' experience in big and small pharma and biotech. He spent 28 years in Warner Lambert and 8 years as commercial head of ProStrakan before becoming joint (co founder) CEO Internis until exit. Recently Alan was CEO of Ryboquin the gene engineering company and Nanogenics acquired by Ryboquin.

 

Prof. W. H. Stimson FRSE: Chief Scientific Officer 

Bill is the founder of the Department of Immunology at The University of Strathclyde. He has  been involved in eight start-up/spin-out biotech companies. He has been a long -term consultant to five multinational companies including Akzo Nobel, Rhone-Poulenc and Johnson & Johnson. Bill has published 215 scientific papers and 25 patents. He was involved in the use of the first human monoclonal antibodies for cancer therapy.

 

Dr Magnus Nicolson MBA FRSC FRSM : Chairman

Magnus has been a CEO, COO and General Manager of Life Science companies in Europe the US and the Gulf. As COO he listed a company on AMEX. Several small companies he ran have been sold to leading multinationals. He has degrees in Biochemistry, Immunology (MSc &PhD) and an MBA and has taken products all the way from the laboratory to market.

 

 

 


Board

 

Kevin Grainger 

Kevin is a serial technology entrepreneur with over 30 years experience. He has successfully established and exited a number of technology businesses. Kevin established the EOS Technology Investment Syndicate in 2014 which is a group of private angel investors focused on early stage science and technology opportunities.

 

Hazel Allen

Hazel is a chartered accountant, business performance coach and financial engineer of over 20 years’ experience. She has strong commercial and strategic experience including roles at the University of the Highlands and Islands, National Semiconductor Corp & PwC and holds non-executive Director roles in research and commercial organisations. 


Scientific and Medical Advisors

 

 ILC Therapeutics™  is supported by a Scientific Advisory Board led by Professor Bill Stimson and consists of the following experts and practitioners from industry and academia

 

Professor Kathryn Ball – Professor of Biochemistry & Cell Signalling at the Institute of Genetics and Molecular Medicine at the University of Edinburgh

 

Professor Ted Hupp – Chair of Experimental Cancer Research at the University of Edinburgh

 

Professor Shuomo Bhattacharya - Professor of Cardiovascular Medicine at the Wellcome Trust Centre for Human Genetics at the University of Oxford

 

Doctor Cathy Adamson - Lecturer in Molecular Medicine at the University of St Andrews